We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+7.29%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$78.8B
AUM Growth
+$7.07B
Cap. Flow
+$2.22B
Cap. Flow %
2.81%
Top 10 Hldgs %
22%
Holding
3,838
New
237
Increased
1,800
Reduced
1,491
Closed
179

Sector Composition

Rank Sector Weight
1 Technology 11.07%
2 Financials 9.56%
3 Healthcare 8.56%
4 Industrials 6.35%
5 Communication Services 5.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORCL icon
126
Oracle
ORCL
$423B
$110M 0.14%
2,081,536
-45,172
-2% -$2.49M
SBUX icon
127
Starbucks
SBUX
$120B
$110M 0.14%
1,246,089
+61,955
+5% +$5.28M
TTE icon
128
TotalEnergies
TTE
$190B
$109M 0.14%
1,976,821
-654,998
-25% -$34.6M
SYY icon
129
Sysco
SYY
$40.3B
$109M 0.14%
1,269,955
+34,130
+3% +$2.76M
EL icon
130
Estee Lauder
EL
$32B
$109M 0.14%
525,369
+28,383
+6% +$5.51M
KSU
131
DELISTED
Kansas City Southern
KSU
$108M 0.14%
707,930
+10,626
+2% +$1.56M
C icon
132
Citigroup
C
$226B
$107M 0.14%
1,335,727
+47,235
+4% +$3.49M
ACN icon
133
Accenture
ACN
$108B
$106M 0.13%
504,162
+21,861
+5% +$4.26M
NGG icon
134
National Grid
NGG
$81.3B
$106M 0.13%
1,915,239
-30,560
-2% -$1.57M
NFLX icon
135
Netflix
NFLX
$309B
$104M 0.13%
3,225,150
-182,480
-5% -$5.41M
XLY icon
136
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23.2B
$104M 0.13%
1,658,396
+316,416
+24% +$19.3M
AGN
137
DELISTED
Allergan plc
AGN
$103M 0.13%
537,889
-41,722
-7% -$7.53M
LYB icon
138
LyondellBasell Industries
LYB
$19.2B
$102M 0.13%
1,084,638
+10,683
+1% +$979K
WELL icon
139
Welltower
WELL
$171B
$102M 0.13%
1,249,613
-53,051
-4% -$4.54M
TMO icon
140
Thermo Fisher Scientific
TMO
$220B
$102M 0.13%
314,194
-3,962
-1% -$1.2M
PPL
141
PPL Corp
PPL
$26.7B
$102M 0.13%
2,829,226
-36,259
-1% -$1.22M
BIIB icon
142
Biogen
BIIB
$30.7B
$100M 0.13%
337,160
-35,266
-9% -$9.78M
VCSH icon
143
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
$99.4M 0.13%
1,227,261
-32,498
-3% -$2.63M
GLD icon
144
SPDR Gold Trust
GLD
$141B
$99.2M 0.13%
694,333
+43,583
+7% +$6.09M
TT icon
145
Trane Technologies
TT
$106B
$97.4M 0.12%
732,583
+4,902
+0.7% +$621K
DHR icon
146
Danaher
DHR
$144B
$96M 0.12%
705,501
+44,019
+7% +$5.56M
LIN icon
147
Linde
LIN
$226B
$95.7M 0.12%
447,543
-84,547
-16% -$17M
OKE icon
148
Oneok
OKE
$54.5B
$95M 0.12%
1,254,948
+133,398
+12% +$9.54M
EFG icon
149
iShares MSCI EAFE Growth ETF
EFG
$17.3B
$94.2M 0.12%
1,088,871
+16,931
+2% +$1.41M
VCIT icon
150
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.3B
$93.4M 0.12%
1,023,049
+110,024
+12% +$10M

Similar funds

Raymond James & Associates's Q4 2019 Portfolio in Review

As of Q4 2019, Raymond James & Associates held 3,838 positions worth $78.8B, up 9.9% from $71.7B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Raymond James & Associates's Q4 2019 filing shows 237 new, 1,800 increased, 1,491 reduced and 179 closed positions. Its largest new stake was Direxion Daily S&P 500 Bear 1X ETF: 343,036 shares worth $8.38M. The largest sale was iShares Core MSCI EAFE ETF, an estimated $325M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q4 2019 buy was Direxion Daily S&P 500 Bear 1X ETF: 343,036 shares worth $8.38M.
  • Raymond James & Associates added most to Vanguard High Dividend Yield ETF in Q4 2019, an estimated $672M increase.
  • Raymond James & Associates's biggest Q4 2019 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $325M.
  • Raymond James & Associates fully exited SunTrust Banks, Inc. in Q4 2019, selling an estimated $45.9M.
  • Raymond James & Associates's ten largest holdings make up 22% of its $78.8B portfolio in Q4 2019.
  • Raymond James & Associates opened 237 new positions and closed 179 in Q4 2019.
  • Raymond James & Associates's portfolio value rose 9.9% quarter-over-quarter to $78.8B.

Based on Raymond James & Associates's 13F filing for Q4 2019, filed 12 Feb 2020.